312 related articles for article (PubMed ID: 15727423)
1. Convection-enhanced delivery in clinical trials.
Hall WA; Rustamzadeh E; Asher AL
Neurosurg Focus; 2003 Feb; 14(2):e2. PubMed ID: 15727423
[TBL] [Abstract][Full Text] [Related]
2. Convection-enhanced delivery: targeted toxin treatment of malignant glioma.
Hall WA; Sherr GT
Neurosurg Focus; 2006 Apr; 20(4):E10. PubMed ID: 16709015
[TBL] [Abstract][Full Text] [Related]
3. Convection-enhanced delivery of targeted toxins for malignant glioma.
Hall WA; Sherr GT
Expert Opin Drug Deliv; 2006 May; 3(3):371-7. PubMed ID: 16640497
[TBL] [Abstract][Full Text] [Related]
4. Convection enhanced delivery of IL13-PE38QQR for treatment of recurrent malignant glioma: presentation of interim findings from ongoing phase 1 studies.
Kunwar S
Acta Neurochir Suppl; 2003; 88():105-11. PubMed ID: 14531568
[TBL] [Abstract][Full Text] [Related]
5. Imaging of convection enhanced delivery of toxins in humans.
Mehta AI; Choi BD; Raghavan R; Brady M; Friedman AH; Bigner DD; Pastan I; Sampson JH
Toxins (Basel); 2011 Mar; 3(3):201-6. PubMed ID: 22069706
[TBL] [Abstract][Full Text] [Related]
6. Intraparenchymal and intratumoral interstitial infusion of anti-glioma monoclonal antibody 8H9.
Luther N; Cheung NK; Dunkel IJ; Fraser JF; Edgar MA; Gutin PH; Souweidane MM
Neurosurgery; 2008 Dec; 63(6):1166-74; discussion 1174. PubMed ID: 19057330
[TBL] [Abstract][Full Text] [Related]
7. Safety of intraparenchymal convection-enhanced delivery of cintredekin besudotox in early-phase studies.
Kunwar S; Chang SM; Prados MD; Berger MS; Sampson JH; Croteau D; Sherman JW; Grahn AY; Shu VS; Dul JL; Husain SR; Joshi BH; Pedain C; Puri RK
Neurosurg Focus; 2006 Apr; 20(4):E15. PubMed ID: 16709020
[TBL] [Abstract][Full Text] [Related]
8. Convection-enhanced delivery of immunotoxins and radioisotopes for treatment of malignant gliomas.
Vandergrift WA; Patel SJ; Nicholas JS; Varma AK
Neurosurg Focus; 2006 Apr; 20(4):E13. PubMed ID: 16709018
[TBL] [Abstract][Full Text] [Related]
9. Clinical studies with targeted toxins in malignant glioma.
Rainov NG; Söling A
Rev Recent Clin Trials; 2006 May; 1(2):119-31. PubMed ID: 18473963
[TBL] [Abstract][Full Text] [Related]
10. Future of convection-enhanced delivery in the treatment of brain tumors.
Bidros DS; Liu JK; Vogelbaum MA
Future Oncol; 2010 Jan; 6(1):117-25. PubMed ID: 20021213
[TBL] [Abstract][Full Text] [Related]
11. Convection enhanced drug delivery of novel therapeutic agents to malignant brain tumors.
Ferguson S; Lesniak MS
Curr Drug Deliv; 2007 Apr; 4(2):169-80. PubMed ID: 17456036
[TBL] [Abstract][Full Text] [Related]
12. Clinical trials with intracerebral convection-enhanced delivery of targeted toxins in malignant glioma.
Rainov NG; Gorbatyuk K; Heidecke V
Rev Recent Clin Trials; 2008 Jan; 3(1):2-9. PubMed ID: 18474010
[TBL] [Abstract][Full Text] [Related]
13. Convection-Enhanced Delivery for Management of Malignant Gliomas.
Prabhu SS
Prog Neurol Surg; 2018; 32():152-158. PubMed ID: 29990981
[TBL] [Abstract][Full Text] [Related]
14. Convection-enhanced delivery: from mechanisms to clinical drug delivery for diseases of the central nervous system.
Saito R; Tominaga T
Neurol Med Chir (Tokyo); 2012; 52(8):531-8. PubMed ID: 22976134
[TBL] [Abstract][Full Text] [Related]
15. Convection-enhanced Delivery of Therapeutics for Malignant Gliomas.
Saito R; Tominaga T
Neurol Med Chir (Tokyo); 2017 Jan; 57(1):8-16. PubMed ID: 27980285
[TBL] [Abstract][Full Text] [Related]
16. Application of Convection-Enhanced Drug Delivery in the Treatment of Malignant Gliomas.
Tykocki T; Miękisiak G
World Neurosurg; 2016 Jun; 90():172-178. PubMed ID: 26898499
[TBL] [Abstract][Full Text] [Related]
17. Effects of drug efflux on convection-enhanced paclitaxel delivery to malignant gliomas: technical note.
Tanner PG; Holtmannspötter M; Tonn JC; Goldbrunner R
Neurosurgery; 2007 Oct; 61(4):E880-2; discussion E882. PubMed ID: 17986926
[TBL] [Abstract][Full Text] [Related]
18. Intracerebral infusate distribution by convection-enhanced delivery in humans with malignant gliomas: descriptive effects of target anatomy and catheter positioning.
Sampson JH; Brady ML; Petry NA; Croteau D; Friedman AH; Friedman HS; Wong T; Bigner DD; Pastan I; Puri RK; Pedain C
Neurosurgery; 2007 Feb; 60(2 Suppl 1):ONS89-98; discussion ONS98-9. PubMed ID: 17297371
[TBL] [Abstract][Full Text] [Related]
19. Induction of hyperintense signal on T2-weighted MR images correlates with infusion distribution from intracerebral convection-enhanced delivery of a tumor-targeted cytotoxin.
Sampson JH; Raghavan R; Provenzale JM; Croteau D; Reardon DA; Coleman RE; Rodríguez Ponce I; Pastan I; Puri RK; Pedain C
AJR Am J Roentgenol; 2007 Mar; 188(3):703-9. PubMed ID: 17312057
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive outlook on intracerebral therapy of malignant gliomas.
Buonerba C; Di Lorenzo G; Marinelli A; Federico P; Palmieri G; Imbimbo M; Conti P; Peluso G; De Placido S; Sampson JH
Crit Rev Oncol Hematol; 2011 Oct; 80(1):54-68. PubMed ID: 20888252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]